| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.034 | 0.4 |